dehydroepiandrosterone has been researched along with Metrorrhagia in 1 studies
Dehydroepiandrosterone: A major C19 steroid produced by the ADRENAL CORTEX. It is also produced in small quantities in the TESTIS and the OVARY. Dehydroepiandrosterone (DHEA) can be converted to TESTOSTERONE; ANDROSTENEDIONE; ESTRADIOL; and ESTRONE. Most of DHEA is sulfated (DEHYDROEPIANDROSTERONE SULFATE) before secretion.
dehydroepiandrosterone : An androstanoid that is androst-5-ene substituted by a beta-hydroxy group at position 3 and an oxo group at position 17. It is a naturally occurring steroid hormone produced by the adrenal glands.
Metrorrhagia: Abnormal uterine bleeding that is not related to MENSTRUATION, usually in females without regular MENSTRUAL CYCLE. The irregular and unpredictable bleeding usually comes from a dysfunctional ENDOMETRIUM.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The pattern of breakthrough bleeding did not substantially differ between the DHEA and PL groups and no significant adverse endometrial effects were apparent." | 2.74 | The safety of 52 weeks of oral DHEA therapy for postmenopausal women. ( Adams, J; Bell, RJ; Davis, SR; Jane, F; Morrow, C; Panjari, M, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Panjari, M | 1 |
| Bell, RJ | 1 |
| Jane, F | 1 |
| Adams, J | 1 |
| Morrow, C | 1 |
| Davis, SR | 1 |
1 trial available for dehydroepiandrosterone and Metrorrhagia
| Article | Year |
|---|---|
The safety of 52 weeks of oral DHEA therapy for postmenopausal women.
Topics: Administration, Oral; Blood Glucose; Dehydroepiandrosterone; Dose-Response Relationship, Drug; Doubl | 2009 |